René Rückert
Direttore operativo presso Isarna Therapeutics GmbH
Profilo
René Rückert is currently the Chief Operating Officer at Isarna Therapeutics GmbH.
He started this position in 2019.
Dr. Rückert has a Master's in Business Administration from Warwick Business School and a doctorate from Charité - Universitätsmedizin Berlin.
Posizioni attive di René Rückert
| Società | Posizione | Inizio |
|---|---|---|
Isarna Therapeutics GmbH
 Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Direttore operativo | 01/01/2019 |
Formazione di René Rückert
| Charité - Universitätsmedizin Berlin | Doctorate Degree |
| Warwick Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Isarna Therapeutics GmbH
Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Health Technology |
- Borsa valori
- Insiders
- René Rückert
